NLRP3 Inflammasome and Mineralocorticoid Receptors Are Associated with Vascular Dysfunction in Type 2 Diabetes Mellitus
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NLRP3 Inflammasome and Mineralocorticoid Receptors Are Associated with Vascular Dysfunction in Type 2 Diabetes Mellitus
Authors
Keywords
-
Journal
Cells
Volume 8, Issue 12, Pages 1595
Publisher
MDPI AG
Online
2019-12-09
DOI
10.3390/cells8121595
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension
- (2017) Yeong Hann Ling et al. PHARMACOLOGICAL RESEARCH
- NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular DamageClinical Perspective
- (2016) Thiago Bruder-Nascimento et al. CIRCULATION
- Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice
- (2015) S M Krishnan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type 2 diabetes mellitus
- (2015) Marcondes Alves B. Silva et al. CLINICAL SCIENCE
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation
- (2015) Nathanne S. Ferreira et al. Frontiers in Pharmacology
- Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO/GC signaling
- (2015) Marcondes A. B. Silva et al. Frontiers in Physiology
- The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats
- (2014) Susana Vallejo et al. Cardiovascular Diabetology
- Spironolactone Decreases DOCA–Salt–Induced Organ Damage by Blocking the Activation of T Helper 17 and the Downregulation of Regulatory T Lymphocytes
- (2014) Cristián A. Amador et al. HYPERTENSION
- Mizoribine Ameliorates Renal Injury and Hypertension along with the Attenuation of Renal Caspase-1 Expression in Aldosterone-Salt-Treated Rats
- (2014) Toshiki Doi et al. PLoS One
- The involvement of aldosterone on vascular insulin resistance: implications in obesity and type 2 diabetes
- (2014) Thiago Bruder-Nascimento et al. Diabetology & Metabolic Syndrome
- Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II
- (2013) Joshua A. Beckman et al. EUROPEAN HEART JOURNAL
- Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
- (2013) Francesco Paneni et al. EUROPEAN HEART JOURNAL
- Mechanisms of Diabetic Complications
- (2013) Josephine M. Forbes et al. PHYSIOLOGICAL REVIEWS
- Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways
- (2012) Ana M. Briones et al. HYPERTENSION
- Vascular Actions of Aldosterone
- (2012) Marie Briet et al. JOURNAL OF VASCULAR RESEARCH
- Aldosterone stimulates nuclear factor-kappa B activity and transcription of intercellular adhesion molecule-1 and connective tissue growth factor in rat mesangial cells via serum- and glucocorticoid-inducible protein kinase-1
- (2011) Yoshio Terada et al. Clinical and Experimental Nephrology
- Mitochondria: Sovereign of inflammation?
- (2011) Jürg Tschopp EUROPEAN JOURNAL OF IMMUNOLOGY
- T Regulatory Lymphocytes Prevent Aldosterone-Induced Vascular Injury
- (2011) Daniel A. Kasal et al. HYPERTENSION
- Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice
- (2010) Michael G. Usher et al. JOURNAL OF CLINICAL INVESTIGATION
- A role for mitochondria in NLRP3 inflammasome activation
- (2010) Rongbin Zhou et al. NATURE
- Deletion of Mineralocorticoid Receptors From Macrophages Protects Against Deoxycorticosterone/Salt-Induced Cardiac Fibrosis and Increased Blood Pressure
- (2009) Amanda J. Rickard et al. HYPERTENSION
- Aldosterone Promotes Autoimmune Damage by Enhancing Th17-Mediated Immunity
- (2009) Andrés A. Herrada et al. JOURNAL OF IMMUNOLOGY
- Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles
- (2008) K. Swaminathan et al. DIABETOLOGIA
- Aldosterone and Vascular Inflammation
- (2008) Nancy J. Brown HYPERTENSION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started